Assertio Holdings Cash Conversion Cycle 2011-2026 | ASRT

Annual Cash Conversion Cycle Assertio Holdings

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
467	371	327	188	119	95.5	-423	-10.6	61	74.5	-39.8	203	113	492	231

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
492	-423	151

Quarterly Cash Conversion Cycle Assertio Holdings

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	294	423	524	-	437	361	320	-	336	267	247	-	224	165	136	-	-34.1	18	87.2	-	73.4	142	-328	-	-449	-240	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
524	-449	150

Cash Conversion Cycle of other stocks in the Drug manufacturers industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Endo International plc ENDP	141	-	-	$ 28.9 M	Irlanda
Evoke Pharma EVOK	55.1	-	-	$ 36.6 M	USA
Cumberland Pharmaceuticals CPIX	-227	$ 5.72	-2.39 %	$ 85 M	USA
HEXO Corp. HEXO	775	-	2.45 %	$ 38.1 M	Canada
AcelRx Pharmaceuticals ACRX	-38	-	7.5 %	$ 6.35 M	USA
DURECT Corporation DRRX	-4.1 K	-	-	$ 50.1 M	USA
Adamis Pharmaceuticals Corporation ADMP	-224	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	460	-	-	$ 754 M	USA
Agile Therapeutics AGRX	-206	-	10.11 %	$ 58.2 M	USA
Alimera Sciences ALIM	-128	-	-	$ 142 M	USA
Cronos Group CRON	61.7	$ 2.79	0.72 %	$ 1.07 B	Canada
Athenex ATNX	137	-	-23.39 %	$ 1.76 M	USA
Harrow Health HROW	-46.2	$ 33.46	1.09 %	$ 1.23 B	USA
Avadel Pharmaceuticals plc AVDL	192	-	-	$ 2.06 B	France
Catalent CTLT	110	-	-	$ 11.5 B	USA
Organogenesis Holdings ORGO	106	$ 2.48	4.2 %	$ 314 M	USA
Eagle Pharmaceuticals EGRX	139	-	-39.89 %	$ 27.7 M	USA
Canopy Growth Corporation CGC	177	$ 1.02	-	$ 110 M	Canada
Pacira BioSciences PCRX	209	$ 23.21	1.53 %	$ 1.07 B	USA
Sonoma Pharmaceuticals SNOA	150	$ 1.11	1.83 %	$ 1.38 M	USA
Aurora Cannabis ACB	1.45 K	$ 3.38	-0.88 %	$ 185 M	Canada
Jupiter Wellness JUPW	-186	-	-	$ 33.6 M	USA
Lannett Company LCI	173	-	1.15 %	$ 7.11 M	USA
OrganiGram Holdings OGI	2.92 K	$ 1.08	0.93 %	$ 103 M	Canada
Tilray TLRY	169	$ 5.17	2.78 %	$ 3.19 B	Canada
Evolus EOLS	74.8	$ 6.7	0.3 %	$ 432 M	USA
Emergent BioSolutions EBS	360	$ 7.95	-0.63 %	$ 425 M	USA
Veru VERU	19.6	$ 3.1	3.33 %	$ 45.4 M	USA
cbdMD YCBD	83	$ 0.72	-0.69 %	$ 2.9 M	USA
ProPhase Labs PRPH	136	-	-	$ 5.07 M	USA
Radius Health RDUS	-35	-	-	$ 1.42 B	USA
Bausch Health Companies BHC	79.8	$ 5.17	1.17 %	$ 1.92 B	Canada
PetIQ PETQ	53.8	-	1.64 %	$ 400 M	USA
Recro Pharma REPH	105	-	-4.76 %	$ 65.3 M	USA
OptiNose OPTN	491	-	-	$ 1.08 B	USA
SCYNEXIS SCYX	2.74	$ 4.36	-2.02 %	$ 218 M	USA
PLx Pharma PLXP	113	-	-27.8 %	$ 2.56 M	USA
Viatris VTRS	150	$ 16.2	1.69 %	$ 18.9 B	USA
Zomedica Corp. ZOM	154	-	-0.21 %	$ 98 M	USA
Zynerba Pharmaceuticals ZYNE	14.6 K	-	-	$ 55.5 M	USA
Rockwell Medical RMTI	57	$ 0.69	3.81 %	$ 24.8 M	USA
China Pharma Holdings CPHI	139	$ 0.72	0.75 %	$ 3.09 M	China
TherapeuticsMD TXMD	-723	$ 1.88	-	$ 21.7 M	USA